Equity in Access to Cancer Cachexia Clinical Trials RFP

Well-being, Health and Biomedical Discovery


Academic Unit: inquire with unit

Memorial Deadline: Monday 27th, June 2022

External Deadline: Thursday 30th, June 2022


Pfizer Global Medical Grants (GMG) supports the global healthcare community’s independent initiatives (e.g., research, quality improvement, or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s GMG competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a general area of interest, sets timelines for review and approval, and uses an internal Pfizer review process to make final grant decisions. Organizations are invited to submit an application addressing the practice gaps as outlined in the specific RFP.

For all independent quality improvement grants, the grant requester (and ultimately the grantee) is responsible for the design, implementation, and conduct of the independent initiative supported by the grant. Pfizer must not be involved in any aspect of project development, nor the conduct or monitoring of the quality improvement program.

Geographic Scope: Global

Clinical Area: Cachexia

Link to full RFP: Equity in Access to Cancer Cachexia Clinical Trials

Application Due Date: June 30, 2022

Specific Area of Interest: Projects that will be considered for Pfizer support will focus on supporting initiatives to improve identification and equity in access to cancer cachexia clinical trials.

Funding Sources

Pfizer Inc

This opportunity was posted by: RGCS

Last modified: May 13, 2022